Tsang, Tim K.
Sullivan, Sheena G.
Meng, Yu
Lai, Francisco Tsz Tsun
Fan, Min
Huang, Xiaotong
Lin, Yun
Peng, Liping
Zhang, Chengyao
Yang, Bingyi
Ainslie, Kylie E. C.
Cowling, Benjamin J.
Article History
Received: 3 June 2024
Accepted: 29 August 2024
First Online: 12 September 2024
Declarations
:
: The study protocol was approved by the Institutional Review Board of the University of Hong Kong and the Hong Kong Department of Health Ethics Committee (IRB reference number: UW 21‐393).
: Not applicable.
: BJC reports honoraria from AstraZeneca, Fosun Pharma, GSK, Haleon, Moderna, Novavax, Pfizer, Roche, and Sanofi Pasteur. SGS reports honoraria from CSL Seqirus, Evo Health, Moderna, Novavax, and Pfizer. All other authors declare that they have no competing interests.